Femtech

InvestmentPitch Media Video Discusses Zero Candida, an Israeli FemTech Medical Device Start-Up with Plans to Apply to List on the TSX Venture Exchange

Retrieved on: 
Mercoledì, Giugno 5, 2024
Fungal infection, Blue Light, Sheep, Clinical trial, Disease, Recurrence, Health, Vagina, Disability, Developed country, Femtech, Vulva, Hospital, Gynaecology, Animal, News, Woman, Quality of life, TSX Venture Exchange, Pharmaceutical industry

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2024) - Zero Candida, an Israeli FemTech medical device start-up, will be applying to list on the TSX Venture Exchange, with a proposed valuation of 40 million dollars Canadian.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - June 5, 2024) - Zero Candida, an Israeli FemTech medical device start-up, will be applying to list on the TSX Venture Exchange, with a proposed valuation of 40 million dollars Canadian.
  • For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company.
  • Zero Candida has a potential to become a technological leader and using its ground-breaking technology to expand boundaries of non-chemical candida treatment."
  • Zero Candida's device will bring the field of gynecology into the 21st century with hybrid medicine and technology-based diagnostics.

Province, the Nationally Recognized Restructuring and Financial Advisory Firm, Appoints Healthcare Veteran Kaile Zagger as Managing Director and Chair of Its Healthcare Practice Group

Retrieved on: 
Mercoledì, Maggio 8, 2024
Legal, Insurance, Finance, Consulting, Banking, Accounting, Professional Services, Other Health, Health, Organization, American College, Femtech, Fortune 500, Purdue Pharma, Patient, Trust, Multimedia, Insys Therapeutics, Therapy, Biotechnology, Pharmaceutical industry

Province takes special pride in announcing the appointment of renowned healthcare executive Kaile Zagger, to lead their nationally recognized innovative healthcare practice group.

Key Points: 
  • Province takes special pride in announcing the appointment of renowned healthcare executive Kaile Zagger, to lead their nationally recognized innovative healthcare practice group.
  • Ms. Zagger brings more than two decades of executive leadership healthcare experience in publicly traded and privately held healthcare organizations.
  • Province was retained in a leading role in various healthcare cases such as Purdue Pharma, Insys Therapeutics, Mallinckrodt, Codiak, and Mariner Healthcare.
  • Province has provided these and other clients with successful corporate and financial advisory as well as litigation services.

ARC Fertility Named Finalist for Two Categories at FemTech World Awards 2024

Retrieved on: 
Martedì, Maggio 7, 2024
Other Health, Professional Services, LGBTQ+, Consumer, HVAC, Hospitals, Health Insurance, Baby, Maternity, Women, Insurance, Manufacturing, Health, FACS, FRCSC, Femtech, Fertility, MD, FACOG, Patient, ARC, Wellbeing of Women

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly announces its selection as a finalist in two categories at the recently held prestigious FemTech World Awards 2024 ceremony.

Key Points: 
  • ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly announces its selection as a finalist in two categories at the recently held prestigious FemTech World Awards 2024 ceremony.
  • The FemTech Awards, recognizing outstanding achievements in women's health technology, shortlisted ARC for the "Company of the Year," sponsored by Guidea and "Gender Inclusive Employer," sponsored by Wellbeing of Women.
  • “Our FertilityNow app exemplifies the ability of FemTech to empower patients by providing a user-friendly platform that facilitates informed decision-making and personalized fertility journeys,” says Dr. Adamson.
  • “Through a strategic fusion of personalized care, virtual accessibility, evidence-based practices, user-friendly interfaces and cutting-edge apps, ARC Fertility continues to redefine the future of reproductive care in a concise and impactful manner.”

ARC Fertility Named as Finalist for Femtech World's Company of the Year Award

Retrieved on: 
Lunedì, Aprile 15, 2024
LGBTQ+, Professional Services, Family, Data Management, Consumer, Technology, Health Technology, Health Insurance, Parenting, Baby, Maternity, Insurance, Women, Health, Femtech, Fertility, MD, Organization, ARC, Nursing

ARC Fertility (ARC) , a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers, health plans, unions and their members, is honored to announce its selection as one of the seven remarkable femtech innovators shortlisted for Femtech World's prestigious Company of the Year award .

Key Points: 
  • ARC Fertility (ARC) , a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers, health plans, unions and their members, is honored to announce its selection as one of the seven remarkable femtech innovators shortlisted for Femtech World's prestigious Company of the Year award .
  • Sponsored by Guidea, a renowned product design agency specializing in digital health design, this award recognizes organizations at the forefront of revolutionizing women's health and wellness.
  • "We are thrilled and honored to be recognized as a finalist for Femtech World's Company of the Year award and flattered to be included in this remarkable group of the best solutions in the world,” says David Adamson, MD, founder and CEO, ARC.
  • Femtech World's Company of the Year award highlights companies that have demonstrated exceptional innovation, impact, and commitment to advancing women's healthcare globally.

Nest Collaborative's Judith Nowlin Recipient of the 2024 Colorado Titan 100 Leadership Award

Retrieved on: 
Giovedì, Aprile 18, 2024
Femtech, Mother, Magness Arena, Health, Creativity, Organization

DENVER, April 18, 2024 /PRNewswire/ -- Titan CEO and headline sponsor Wipfli LLP are pleased to announce Judith Nowlin, CEO of Nest Collaborative as a 2024 Colorado Titan 100.

Key Points: 
  • DENVER, April 18, 2024 /PRNewswire/ -- Titan CEO and headline sponsor Wipfli LLP are pleased to announce Judith Nowlin, CEO of Nest Collaborative as a 2024 Colorado Titan 100.
  • Collectively the 2024 Colorado Titan 100 and their companies employ over 74,000 individuals and generate over $43 billion in annual revenues.
  • Honorees will attend an awards ceremony on May 30th, 2024 at Magness Arena in Denver, CO.
    "The Titan 100 are changing the way that business is done in Colorado.
  • We proudly recognize the Titan 100 for their efforts to shape the future of the Colorado business community.

Inc.’s 2024 Female Founders list highlights why female founders are always a good bet

Retrieved on: 
Martedì, Aprile 9, 2024
BCG, Genomics, AngelList, Organization, Growth, Female, Environment, Rihanna, Research, University, Entrepreneurship, Private sector, Doctor of Philosophy, Biology, Woman, Male, STEM, Molecular biology, Femtech, UW, Hedera, Nursing

Elizabeth Ruzzo, CEO and founder of adyn, was recognized by Inc. in this year’s Female Founders list.

Key Points: 
  • Elizabeth Ruzzo, CEO and founder of adyn, was recognized by Inc. in this year’s Female Founders list.
  • The female founders on this year’s list are a testament to what triumph over adversity looks like.
  • “One thing I bet all founders on this list share is an abundance of grit and determination.
  • Despite years of evidence demonstrating that female founders are a good bet, the fundraising environment remains bleak.

ELVIE PUTS MATERNAL SUPPORT UNDER A MICROSCOPE WITH NEW REPORT

Retrieved on: 
Martedì, Aprile 9, 2024
Mother, BUT, Health, Face, Woman, Lactation, Partnership, Education, Periodic function, Mental health, Research, Sleep, The Motherload, Femtech, Breastfeeding, Policy, Prenatal care, Postpartum period, Pregnancy, Thought, Biology, Loneliness, Animation, Pelvic floor, Baby Blues, Family, Marketing, Frustration, Birth control

NEW YORK, April 9, 2024 /PRNewswire/ -- Today, Elvie, the disruptive global FemTech health and wellness brand, releases "The Motherload: The weight of limited postpartum support," their first-ever report, in partnership with Mother.ly, putting the state of maternal health under the microscope. The study of over 1,000 women with children has uncovered a trio of serious pregnancy and postpartum challenges that mothers currently face. 

Key Points: 
  • As a female-founded and female-grounded company, Elvie has worked tirelessly to empower women through radical female-first technology that harnesses their incredible biology.
  • "With this new research, we're demonstrating something those mothers already know: postpartum care in the US is simply not good enough."
  • Only 28% say they had good mental health during the postpartum period, but only 31% had professional mental health support.
  • While mothers understand that postpartum challenges are guaranteed, they're often complicated by a lack of strong structural support and poor paid maternity leave policies.

Cosm Medical Achieves FDA Clearance for Gynethotics™ Pessaries, Pioneering the future of personalized pelvic care

Retrieved on: 
Giovedì, Marzo 14, 2024
Research, Medical Devices, Medical Supplies, FDA, Clinical Trials, Other Health, Biotechnology, Health, Science, Other Science, Pessary, Medicine, Partnership, Patient, Journal, Incontinence, University, Femtech, Health Canada, Trial of the century, Woman, Gynaecology, Prolapse, Birth control

Cosm Medical proudly announces FDA clearance for Gynethotics™ Pessaries, marking it as the first personalized pessary available to patients.

Key Points: 
  • Cosm Medical proudly announces FDA clearance for Gynethotics™ Pessaries, marking it as the first personalized pessary available to patients.
  • This milestone follows a recent Health Canada clearance and marks a significant advancement in pelvic care, emphasizing Cosm’s commitment to enhancing patient outcomes and revolutionizing treatment options for women worldwide.
  • Gynethotics™ are the first pessary to be FDA cleared in about 5 years with almost 10 million pessary configurations that clinicians can conveniently order online.
  • “Our vision is to become the world leader in precision gynecological devices for unique bodies and needs.” said Derek Sham, Founder & CEO of Cosm Medical.

Zcube Launches the 2024 Edition of Open Accelerator, an International Acceleration Program Aimed at Life Sciences Startups with Focus on Women's Health and Femtech

Retrieved on: 
Mercoledì, Febbraio 28, 2024
Health, Venture Capital, Neurology, Finance, Consumer, Other Health, Professional Services, Oncology, Other Science, Mental Health, General Health, Science, Women, Cardiology, Cervical cancer, Mental health, Call, Investment, Physician, Partnership, Femtech, Venture capital, Gynaecology, Endocrinology, Ecosystem, SAFE, Patient, Intellectual property, Diagnosis, HTH, Community, Wi-Fi Direct, Gastroenterology, Pharmaceutical industry

Zcube - Zambon Research Venture announces the fifth edition of Open Accelerator, the international acceleration program for high-potential innovative startups in the field of life sciences.

Key Points: 
  • Zcube - Zambon Research Venture announces the fifth edition of Open Accelerator, the international acceleration program for high-potential innovative startups in the field of life sciences.
  • Starting this year, the program will focus on the femtech sector and will feature a new format.
  • The targeted therapeutic areas include gynecology, cardiovascular health, oncology, sexual health, endocrinology, gastroenterology, nutrition, autoimmune disorders, mental health, neurology, reproductive health, and more.
  • The Call for application will open on Friday, March 8, 2024, on the International Women's Day, and will remain open until June 16.

The State of Feeding Survey Reveals Only 40% of New Moms Meet Personal Baby Feeding Expectations, Highlighting an Alarming Gap in Baby Feeding Education and Support

Retrieved on: 
Martedì, Marzo 5, 2024
SAN, Workplace, Education, Culture, Parent, Pregnancy, Entrepreneurship, Motherboard, Lactation, Breast, Parental leave, Health, Stigma, Parenting, Report, Mother, Infant, Federal, Combo, CDC, Femtech, Partnership, Birth control

SAN FRANCISCO and ITHACA, N.Y., March 5, 2024 /PRNewswire/ -- In a step towards empowering parents' diverse feeding journeys, Willow Innovations, Inc. (Willow), the leading FemTech brand changing how moms breastfeed; Bobbie, the mom-founded pediatric nutrition company; and SimpliFed, a digital lactation consultant network democratizing feeding support, released the findings from their inaugural State of Feeding Survey and Report. These findings are the culmination of a rare partnership that closes the divide within the baby-feeding industry and marks a significant stride in creating a holistic and inclusive approach to support mothers. The State of Feeding survey data underscores the feeding realities of new moms to redefine expectations and allow parents to embrace their unique journeys on their terms.

Key Points: 
  • The State of Feeding survey data underscores the feeding realities of new moms to redefine expectations and allow parents to embrace their unique journeys on their terms.
  • According to the State of Feeding survey, nearly 100% of prepartum and postpartum moms had a plan for how they would feed their babies.
  • 11% of moms intended for a combination of feeding (also known as "Combo Feeding") with breastfeeding, pumping, and formula feeding; however, 65% were combination feeding.
  • Moms who formula feed or pump are less likely to receive support and education, despite the majority of moms are combination feeding.